The derivatives etoposide and teniposide have been successfully utilized in the treatment of a variety of malignant conditions .

依托泊甙、 替 尼 泊 甙已经成功地用于临床抗肿瘤治疗。

A Pharmacokinetic Study of Teniposide in Intraperitoneal Chemotherapy of Ovarian Cancer

替 尼 泊 甙 用于卵巢癌患者腹腔化疗的药代动力学研究

Chemotherapy wiht teniposide and nimustine in 20 cases with metastatic brain tumors

联合应用 替 尼 泊 苷和尼莫司汀治疗20例转移性脑肿瘤

Teniposide and lomustine plus combination chemotherapy in the prevention of brain metastasis in lung cancer patients

替 尼 泊 苷和洛莫司汀加用于联合化疗中预防肺癌脑转移

Results : In both the regimens fludarabine and VM ( teniposide + MIT ) the complete remission ( CR ) rate was 45 % versus 31.8 % ( P > 0.05 );

结果：以Flu为主的方案与 替 尼 泊 苷 +MIT方案（VM）相比：完全缓解（CR）率分别为45%和31.8%，P>0.05；

Methods 23 patients was randomly treated with teniposide plus CHOP regimens .

方法以 替 尼 泊 甙联合CHOP方案随机治疗23例 恶性 淋巴瘤，按 全国 统一标准 评定疗效。

The RR of combination chemotherapy containing teniposide in brain tumors was 46 2 % with 52 6 % in primary brain tumor .

替 尼 泊 甙联合化疗对脑瘤的有 效率为 462%，其中对脑胶质瘤的有 效率为526%。

Inhibitory effect of thalidomide combined with low-dose teniposide on transplanted human gastric adenocarcinoma BGC-823 tumor in nude mice

低剂量 替 尼 泊 苷联合沙利度胺对人胃癌移植瘤的抑制作用

Teniposide cyclophosphamide and dexamethasone combination treatment for stage ⅲ multiple myeloma : a report of 21 cases

鬼臼 噻吩 甙、环磷酰胺和地塞米松治疗Ⅲ期多发性骨髓瘤21例报告

Thus the aim of this study was to prepare and evaluate a stable teniposide sub-microemulsion injection ( TSE ) . An HPLC method was established for the analysis of teniposide in vitro .

本研究的目的是制备并评价一种稳定的 替 尼 泊 苷亚微乳注射液（TSE）。本论文建立了替尼泊苷HPLC体外分析方法，该方法重现性好，准确度高。

Teniposide and Nimustine Combination Therapy for Patients with MGMT Negative Gliomas : Experience of 18 cases

替 尼 泊 苷与尼莫司汀联合治疗MGMT阴性表达的恶性胶质瘤：附18例经验

Purpose : To study the antiproliferative effect of tricyclic antidepressant desipramine ( DMI ) alone or in combination with chemotherapeutic agent teniposide ( VM 26 ) against rat C6 glioma cells .

目的：研究三环类抗抑郁药地昔帕明（DMI）对脑胶质瘤C6细胞增殖的调控作用，并探讨与临床常用治疗 脑瘤的化疗药物 替 尼 泊 苷（ VM26）合用的协同效应。

Paclitaxel and Teniposide Combination Chemotherapy for Patients with Malignant Astrocytic Brain Tumors

紫杉醇与 替 尼 泊 苷联合化疗治疗脑恶性胶质瘤

Chemosensitivity testing of oral squamous cell carcinomas with teniposide

替 尼 泊 甙对口腔鳞癌化疗敏感性的体外研究

Clinical study of teniposide in combination with cisplatin in treatment of lung cancer

替 尼 泊 甙加顺铂联合治疗肺癌的临床研究

OBJECTIVE : To define the activity and toxicity of teniposide in combination with cisplatin in treatment of lung cancer .

目的：研究 替 尼 泊 甙加顺铂联合治疗肺癌患者的疗效和毒性。

From August 1993 to May 1995 cases of advanced NSCLC were confirmed by pathologic or histologic investigation and were treated with teniposide ( VM-26 ) combined with cisplatin ( PDD ) .

1993年8月至1995年3月，用 威猛（VM－26）加顺铂（PDD）组成的方案治疗均经病理学或细胞学证实的晚期非小细胞肺癌（NSCLC）30例。

Effect of desipramine alone and in combination with teniposide on proliferation in rat C6 glioma cells

地昔帕明单用和合用 替 尼 泊 苷对大鼠脑胶质瘤C6细胞增殖的调控作用

Study on the Mechanism for Topoisomerase ⅱ Poison Teniposide Against Oral Cancer Cells

拓扑异构酶抑制剂替 尼 泊 甙抗口腔癌机制的研究 替 尼 泊 甙对口腔鳞癌化疗 敏感性的体外研究

The fluorescence detector measured the Vp - 16 and teniposide ( VM - 26 ) with the excitation wavelength of 220 nm and the emission wavelength of 330 nm .

荧光检测以220nm波长激发光及330nm波长检测Vp-16及 替 尼 泊 苷（VM-26）。

Chemotherapy with higher or lower dose of teniposide combined with cisplatin and pingyangmycin for oral squamous cell carcinoma

不同剂量 替 尼 泊 苷联合化疗方案治疗口腔鳞癌的 前瞻性研究

Teniposide and Cisplatin Compared with Etoposide and Cisplatin for Treatment of Small Cell Lung Cancer

替 尼 泊 甙联合顺铂与足叶乙甙联合顺铂治疗小细胞肺癌的疗效比较

The rate of inhibition of teniposide ( VM-26 ) and etoposide ( VP-16 ) on ALL cells was higher that on ANLL cells .

替 尼 泊 苷（VM-26）和VP-16对ALL细胞的抑制率高于ANLL细胞；

Effect of Combined Chemotherapy with Teniposide on Gastric Cancer Cells

以 替 尼 泊 甙为主联合用药对胃癌细胞的作用

Analysis of Effect of Teniposide Plus CHOP Regimens on Malignant Lymphoma

替 尼 泊 甙方案治疗恶性淋巴瘤疗效分析

Etoposide ( VP-16 ) and teniposide ( VM-26 ) are two semi-synthetic derivatives of podophyllotoxin which have been officially approved for clinical use against various types of cancers including breast cancer testicular cancer non small-cell lung cancer lymphoma and childhood leukemia .

依托泊苷（VP-16）和 替 尼 泊 苷（VM-26）是鬼臼毒素的半合成衍生物，在临床上广泛用于乳腺癌、睾丸癌、非小细胞肺癌、淋巴癌、白血病等的治疗。

Objective To study the effect of calcium antagonist nimodipine ( NMD ) combined with chemotherapy drugs carmustine ( BCNU ) and teniposide ( Vm 26 ) on chemoresistance in malignant glioma cells and provide rational chemotherapy method in clinical .

目的观察钙离子拮抗剂尼莫地平（NMD）与化疗药物卡氮介（BCNU）及 威猛（Vm-26）联合使用对脑胶质瘤细胞化疗耐药性的影响，为临床上脑胶质瘤的合理化疗提供理论依据。

Teniposide ( VM-26 ) can inhibit Topoisomerase ⅱ ( Top ⅱ) that induces DNA strand-breaks and can also block cell circle in the late S nd G2 + M phases .

鬼臼 噻吩 甙（VM-26）能抑制拓扑异构酶（TopⅡ）使DNA单、双链可逆性断裂，并能使细胞阻滞于S后期和G2+M期。

Objective It is to evaluate the curative effects and the relevant toxicty and side effets on curing brain malignant neuroglioma by using teniposide combination chemotherapy .

目的评价 含 替 尼 泊 苷联合化疗方案对恶性脑胶质瘤的治疗效果和毒副作用，探讨有效的辅助化疗方案，以期提高恶性脑神经胶质瘤患者的疗效，延长生存期。

This clinical trial was designed to compare the efficacy and toxicity of teniposide plus cisplatin ( VM 26 + DDP ) regimen and EP regimen in treatment of SCLC and the possible role of VM 26 on prevention of brain metastasis of SCLC .

本研究的目的是观察比较 VM-26联合DDP方案与EP方案治疗SCLC患者的疗效及对脑转移的预防作用。